Zhejiang AngliKang Pharmaceutical Co (SZSE:002940) Accounts Payable & Accrued Expense : ¥593 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Zhejiang AngliKang Pharmaceutical Co Accounts Payable & Accrued Expense?

Zhejiang AngliKang Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥698 Mil) to Dec. 2023 (¥554 Mil) but then increased from Dec. 2023 (¥554 Mil) to Mar. 2024 (¥593 Mil).

Zhejiang AngliKang Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥570 Mil) to Dec. 2022 (¥557 Mil) and declined from Dec. 2022 (¥557 Mil) to Dec. 2023 (¥554 Mil).

Zhejiang AngliKang Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Zhejiang AngliKang Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang AngliKang Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Zhejiang AngliKang Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

335.90

526.21

569.51

556.68

554.41

Zhejiang AngliKang Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															721.38	617.35	698.23	554.41	593.04

Zhejiang AngliKang Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Zhejiang AngliKang Pharmaceutical Co (SZSE:002940) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang AngliKang Pharmaceutical Co Ltd (SZSE:002940) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 1000, North Luzhou Avenue, Zhejiang Province, Quzhou, CHN, 312400

Website

http://www.alkpharm.com

Zhejiang AngliKang Pharmaceutical Co Ltd is engaged in the manufacturing and sale of pharmaceutical materials, pharmaceutic preparations, and medical empty capsules. The main products offered by the group are cephalosporins antibacterial, angiocarpy drugs and gastrointestinal tract drugs. Geographically, the activities are carried out through Shengzhou, China.

Executives

Pan Xiao Yun	Supervisors
Ye Shu Xiang	Director
Yang Guo Dong	Executives
Xu Ai Fang	Supervisors
Wu Zhe Hua	Director

Zhejiang AngliKang Pharmaceutical Co (SZSE:002940) Headlines

No Headlines